15:08 EST Disc Medicine (IRON) says issue raised by FDA ‘readily addressable’
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRON:
- Disc Medicine extends decline after volatility halt
- Disc Medicine plunges after FDA posts complete response letter for bitopertin
- Disc Medicine drops 21% to $56.53 in afternoon plunge
- Iron Planet Inc. trading halted, volatility trading pause
- Disc Medicine: Differentiated EPP Therapy and Asymmetric FDA Catalyst Support Buy Rating